Enact Holdings (ACT) Q4 2025 earnings review
Credit Cures and Capital Returns Mask Flat Core Revenue
Enact Holdings delivered a strong earnings beat in Q4 2025, with Net Income rising 9% YoY to $177 million ($1.22/share). However, the quality of earnings is mixed: the result was driven primarily by a $60 million reserve release (cutting the loss ratio to 7%) and higher investment income, rather than core premium growth. Net Premiums Earned were flat year-over-year at $246 million. Management signaled immense confidence in the balance sheet by authorizing a new $500 million share repurchase program—a massive commitment relative to the ~$503 million returned in all of 2025.
🐂 Bull Case
The Board authorized a new $500 million share repurchase program, on top of the $0.21 quarterly dividend. With PMIERs sufficiency at a robust 162% ($1.9 billion excess), Enact has significant capacity to return cash to shareholders.
The loss ratio dropped to 7% in Q4 (vs 15% in Q3), driven by favorable cure performance. Management officially lowered its claim rate expectation from 9% to 8%, signaling structural confidence in the loan book's resilience.
🐻 Bear Case
Net Premiums Earned have flatlined at ~$246 million for three consecutive quarters. With Persistency dropping to 80%, the company is relying on investment income and reserve releases for earnings growth rather than core premium expansion.
Primary Persistency Rate fell to 80% in Q4, down from 83% in Q3 and 82% a year ago. If churn accelerates further due to rate volatility, Insurance In-Force (IIF) retention will become a significant headwind.
⚖️ Verdict: 🟢
Bullish. While the flat top-line is a concern, the massive $500M buyback authorization and structurally improved credit assumptions (8% claim rate) provide a powerful floor for the stock. The company is effectively over-capitalized and returning that excess aggressively.
Key Themes
Reserve Releases Turbocharge Earnings
Q4 profitability was heavily skewed by credit favorability. A $60 million net reserve release—driven by better cure rates and a reduction in the claim rate assumption from 9% to 8%—pushed the Loss Ratio down to just 7%. This compares to a 10% loss ratio in the prior year period. This is a non-recurring boost but reflects a permanently better view of portfolio risk.
Capital Return Acceleration
Enact returned $503 million to shareholders in 2025. The new $500 million authorization suggests this pace will continue or accelerate in 2026. Given the company's size, this represents a high-yield return of capital strategy that compensates for the lack of top-line explosiveness.
Persistency Headwinds
Persistency dropped to 80% in Q4, a marked decline from 83% in Q3. This metric measures the retention of existing policies; a decline suggests higher prepayments or refinancing activity. This creates a leaky bucket for Insurance In-Force (IIF), requiring higher New Insurance Written (NIW) just to maintain the portfolio size.
Investment Income Tailwinds
Net Investment Income rose to $69 million, up 10% from $63 million in 24Q4. The portfolio is benefiting from the high-interest-rate environment as maturing assets are reinvested at higher yields. This steady income stream provides a buffer against volatility in underwriting results.
Expense Ratio Creep
Operating expenses rose to $59 million in Q4, pushing the expense ratio to 24%, up from 22% in Q3. Management cited incentive-based compensation as the driver. While likely seasonal, it pressured the adjusted operating margin sequentially.
Other KPIs
Accelerating. Up 8% YoY and 2% sequentially. This growth is encouraging given the challenging housing affordability backdrop, suggesting Enact is winning share or the purchase market is stabilizing.
Stable. Up 2% YoY ($269B in 24Q4). Growth is sluggish due to the drop in persistency, which offsets the gains from NIW.
Stable. Remains extremely robust compared to the regulatory minimum. This massive capital cushion is the primary enabler of the new $500M buyback program.
Guidance
New authorization. This replaces/adds to prior programs and signals a commitment to return essentially all excess capital generation to shareholders.
Stable. Payable March 19, 2026. Maintains the increased payout level established earlier in 2025.
Key Questions
Persistency Floor
Persistency dropped 300bps sequentially to 80%. Is this a one-time step down due to a specific rate movement in Q4, or should we model 80% (or lower) as the new normal for 2026?
Claim Rate Sustainability
You lowered the claim rate assumption to 8%, driving a massive reserve release. What macro conditions would force you to revert this back to 9% or higher?
Premium Yield Trajectory
Net Premiums Earned have been flat at $246M for three quarters despite NIW growth. Is the net yield on the portfolio compressing due to mix shift or competitive pricing?